The findings highlight the need to develop measures that could slow the progression of the disease in people who have indications of neuropathological changes that could eventually lead to Alzheimer's dementia, said Ron Brookmeyer, professor of biostatistics at the UCLA Fielding School of Public Health and the study's lead author.
The U.S. National Institute on Aging has more about Alzheimer's disease. And with two-thirds of its annual costs being borne by Medicare and Medicaid, it is one that demands more attention from our government. As a former caregiver to my mother who passed away from Alzheimer's in 2002, I remember well the roller coaster of emotion as we tried to enjoy the season of giving, while at the same time, watching someone we loved endure the ravages of a devastating and heartbreaking disease.
Alzheimer's is the most expensive disease in the U.S.The nation now spends $259 billion a year on Alzheimer's, which is why we need this new approach.
Congress has a chance to take decisive action passing the Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer's Act (S. 2076/H.R. 4256), endorsed by the Alzheimer's Association.
The study findings, which show cases of Alzheimer's and mild cognitive impairment going from 6 million this year to 15 million in four decades, highlight the need to better identify people with a brain-related disease, and to slow its progression. This new bill would create an Alzheimer's public health infrastructure across the country to implement effective Alzheimer's interventions like increasing early detection and diagnosis, reducing risk and preventing avoidable hospitalizations. Maria Cantwell and Patty Murray to fight for the 5 million Americans living with Alzheimer's by co-sponsoring the BOLD Infrastructure for Alzheimer's Act.